United States Patent and Trademark Office, Patent Assignment 23417/366:
Assignment Of Assignors Interest
Assignors
Assignee
Basi, Guriq
Paperwork Executed December 19, 2003
Saldanha, Jose
Paperwork Executed September 3, 2003
Recorded
October 23, 2009
Elan Pharmaceuticals, Inc.
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080-7085
Patents
Correspondent
Humanized Antibodies That Recognize Beta Amyloid Peptide
X0 Patent Application No. 11893123 , Filed August 13, 2007
A1 Application Publication No. 20110142823, Issued June 16, 2011
Humanized Antibodies That Recognize Beta Amyloid Peptide
B2 Utility Patent No. 8128928 , Issued March 6, 2012
Rosemarie L. Celli
Kilpatrick Townsend & Stockton, LLP
TWO EMBARCADERO CENTER, 8TH FLOOR
SAN FRANCISCO, CA 94111
Phone: +1 650 838 2000
Updated March 6, 2012
View this assignment via USPTO Assignments on the Web
Statistics
This assignment has been viewed 4 times.
Information Facts
https://www.plainsite.org/patents/assignment.html?id=4642708
Primary Sources
Government agencies: SEC/EDGAR, federal and state courts, USPTO, IRS, and others
AI text generation None
AI document summarization None
AI-augmented search None
AI-generated images None
AI chat or Q&A interface Linkable via MCP
Third party AI contribution in government documents Possible
Document content is reproduced directly from government sources. Some filings in our database may themselves contain AI-generated content submitted by third parties to government agencies.